skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides

Review

(1891) Views  (473) Full article downloads

Authors: Debra L Breneman, Timothy J Storer, John C Breneman, Diya F Mutasim

Published Date August 2008 Volume 2008:4(5) Pages 1135 - 1141
DOI: http://dx.doi.org/10.2147/TCRM.S1155

Debra L Breneman1, Timothy J Storer2, John C Breneman3, Diya F Mutasim4

1University of Cincinnati Medical Center, Dept of Dermatology, Cincinnati, Ohio, USA; 2Smith Clinic, Delaware, Ohio, USA; 3University of Cincinnati Medical Center, Dept of Radiology, Division of Radiation Oncology, Cincinnati, Ohio, USA; 4University of Cincinnati Medical Center, Dept of Dermatology, Cincinnati, Ohio, USA

Abstract: Methotrexate-induced cutaneous ulceration has rarely been reported in patients with mycosis fungoides. We report 4 patients with mycosis fungoides who developed cutaneous ulceration as an initial manifestation of methotrexate toxicity. Methotrexate dose at the time of ulceration ranged from 10–60 mg. All 4 patients were erythrodermic, which may have predisposed them to this toxic effect. It is important to recognize cutaneous ulceration as an uncommon, but potentially serious, side effect of methotrexate in these patients, and to differentiate it from ulceration due to progressive lymphoma.

Keywords: mycosis fungoides, methotrexate, ulceration, cutaneous T-cell lymphoma, toxicity